← Leaderboards
Markus Bosmann
Boston University Medical Campus
$8,719,887
Attributed
$8,719,887
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,719,887 · 4
By mechanism
R01$8,719,887 · 4
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Karen N. Allen$8,038,772
Others in their field
Other Emerging Leaders on “Molecular”
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,360,557
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$109,548,439
- Leonard Freedmand · Leidos Biomedical Research, Inc.$85,594,314
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Scott Hensley · University Of Pennsylvania$41,662,743
Research focus
MolecularCytokineCellsInsightTranscriptomeFutureInfectionNeutrophilPathway InteractionsProgramsExperimental StudyReportingInvadedPathogenMortalitySeveritiesInflammationPhagocytesImmuneMacrophageBaseBacteriaImmune ResponseMonocyte
Grant awards (17)
Interleukin-27 in host response to Legionella infection$703,685
R01 · FY2025 · HL · contact PI
Interleukin-27 in host response to Legionella infection$689,612
R01 · FY2024 · HL · contact PI
Bacterial polyphosphates in sepsis$537,125
R01 · FY2024 · AI · contact PI
Interleukin-27 in host response to Legionella infection$703,685
R01 · FY2023 · HL · contact PI
Bacterial polyphosphates in sepsis$537,125
R01 · FY2023 · AI · contact PI
Bacterial polyphosphates in sepsis$537,125
R01 · FY2022 · AI · contact PI
Role reversal of MAVS in bacterial sepsis$482,381
R01 · FY2022 · HL · contact PI
New genetic models for C5a receptors$412,500
R01 · FY2022 · HL · contact PI
Bacterial polyphosphates in sepsis$537,125
R01 · FY2021 · AI · contact PI
Role reversal of MAVS in bacterial sepsis$482,381
R01 · FY2021 · HL · contact PI
New genetic models for C5a receptors$412,500
R01 · FY2021 · HL · contact PI
Role reversal of MAVS in bacterial sepsis$482,381
R01 · FY2020 · HL · contact PI
New genetic models for C5a receptors$412,500
R01 · FY2020 · HL · contact PI
Role reversal of MAVS in bacterial sepsis$482,381
R01 · FY2019 · HL · contact PI
New genetic models for C5a receptors$412,500
R01 · FY2019 · HL · contact PI
Role reversal of MAVS in bacterial sepsis$482,381
R01 · FY2018 · HL · contact PI
New genetic models for C5a receptors$412,500
R01 · FY2018 · HL · contact PI